11/12/24 16:08 | 11/8/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,827 | 515.00 | 0 | -15 | -17 | 76 | D | | | | | | | | | | | | | | |
8/1/24 16:17 | 7/30/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,677 | 505.00 | 0 | -15 | -14 | 91 | D | | | | | | | | | | | | | | |
7/24/24 16:05 | 7/22/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,555 | 497.00 | 0 | -15 | -13 | 106 | D | | | | | | | | | | | | | | |
5/29/24 16:08 | 5/24/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -715 | 457.00 | 0 | -2 | -1 | 121 | D | | | | | | | | | | | | | | |
5/22/24 16:21 | 5/20/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -6,795 | 447.00 | 0 | -15 | -11 | 121 | D | | | | | | | | | | | | | | |
12/19/23 16:15 | 12/15/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -6,974 | 407.00 | 0 | -17 | -14 | 109 | D | | | | | | | | | | | | | | |
12/15/23 16:23 | 12/13/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -2,024 | 397.00 | 0 | -5 | -4 | 109 | D | | | | | | | | | | | | | | |
11/15/23 16:16 | 11/13/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -1,922 | 377.00 | 0 | -5 | -4 | 114 | D | | | | | | | | | | | | | | |
7/18/23 16:13 | 7/17/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -2,779 | 355.00 | 0 | -8 | -6 | 119 | D | | | | | | | | | | | | | | |
5/1/23 16:26 | 4/27/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -1,125 | 339.08 | 0 | -3 | -3 | 127 | D | | | | | | | | | | | | | | |
1/27/23 16:13 | 1/25/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,151 | 315.05 | 0 | -10 | -10 | 90 | D | | | | | | | | | | | | | | |
8/17/22 17:40 | 8/15/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,566 | 305.06 | 0 | -12 | -11 | 100 | D | | | | | | | | | | | | | | |
6/28/22 16:05 | 6/24/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,405 | 291.30 | 0 | -12 | -10 | 111 | D | | | | | | | | | | | | | | |